Properties
What is it?
International Nonproprietary Name (Active Substance): comb. drug Clinical-Pharmacological Group: Biologically Active Supplements Manufacturer: PRIMEA Limited Country of Manufacture: United Kingdom Dosage Form: Tablet #30 Dispensing Status: Group III (Over-the-counter) Sambovini Composition: 1 tablet contains: Beta-glucan (derived from oats) - 150 mg; Vitamin C (Ascorbic Acid) - 120 mg; Vitamin E (DL – Alpha Tocopherol) - 50 mg; Zinc (Zinc Oxide) - 25 mg; Selenium (Sodium Selenite) - 150 mcg. Pharmacotherapeutic Group: Immunostimulant, antioxidant, anti-atherosclerotic agent. Indications: - Immunodeficiency conditions; - Viral, bacterial, fungal, and parasitic infections - prophylaxis and treatment; - Physical and mental fatigue; stress; asthenia; - Reproductive function disorders, infertility; - Post-operative period; - Prevention and treatment of skin and soft tissue infections; - Oncological diseases; pre- and post-chemotherapy and radiotherapy periods; - Cardiovascular system diseases; - Atherosclerosis (elevated LDL and triglyceride levels); - Diabetes Mellitus – prophylaxis and complex therapy; - Frequent exacerbations of chronic diseases; - Convalescence period; Dosage and Administration: Sambovini is taken orally, 30 minutes after meals, with water. Children: 6 to 12 years old: 1 tablet once a day. Adults: For prophylaxis: 1 tablet 1-2 times a day; for treatment: 1 tablet 2-3 times a day. Side Effects: Very rarely, individual intolerance reactions to any component of the preparation; Contraindications: Hypersensitivity. Use during Pregnancy and Lactation: Due to the lack of adequate studies, the preparation is prescribed with caution.